A single centre study assessing the EDSS scores in patients on disease modifying therapy
Latest Information Update: 17 Dec 2021
At a glance
- Drugs Alemtuzumab (Primary) ; Cladribine (Primary) ; Daclizumab (Primary) ; Dimethyl fumarate (Primary) ; Fingolimod (Primary) ; Glatiramer acetate (Primary) ; Interferon beta (Primary) ; Natalizumab (Primary) ; Ocrelizumab (Primary) ; Teriflunomide (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 17 Dec 2021 New trial record